University of Leeds, Institute of Psychological Sciences
Leeds, West Yorkshire, LS29JT, United Kingdom
NCT Number: NCT01411631
There is some evidence that polyphenols can affect cognitive function. Therefore, consumption of polyphenols has the potential to prevent cognitive impairment or even enhance cognitive performance. The objective of this study is to investigate the effect of polyphenol consumption served in the form of Concord Grape Juice (CGJ) on cognitive performance and driving performance in Mums.
The study design will be a repeated measures, double-blind, randomised, placebo controlled, crossover study. There will be 2 conditions; CGJ and a placebo drink. 20 participants will undergo two 12 week dietary interventions which will entail daily consumption of a 12oz serving of CGJ or placebo in a counterbalanced manner. There will be a 4 week washout period between conditions. At baseline, 6, and 12 weeks of each 12-week treatment arm cognitive performance and driving performance will be assessed (using the driving simulator at the Institute for Transport Studies). CGJ is a common ingredient in commercially available products.
Mums will be defined as mothers of pre-teen children (aged under 13 years) who are aged 40-50. This population generally have hectic and stressful lifestyles and therefore there is potential for this population to receive cognitive benefit from polyphenol consumption.
Looking for future studies?
Notify Me40 year–50 year
Female
Interventional
Not applicable
Leeds, West Yorkshire, LS29JT, United Kingdom
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will consume grape juice polyphenols for 12 weeks and a control juice for 12 weeks.
Time frame: Measured at baseline, baseline+6 weeks, and baseline+12 weeks of each experimental arm
Cogntive function will be assessed with a battery of cognitive tests, including tests of memory, problem solving skills, concentration, and attention. Driving performance will be assessed using a driving simulator.
Time frame: Measured at baseline, baseline+6 weeks, and baseline+12 weeks of each experimental arm
Blood pressure measures will be taken over a period before, during and after the driving tasks using an ambulatory blood pressure monitor. An Omron M7 ambulatory blood pressure monitor will be used and can be worn during the driving task.
Time frame: Measured at baseline, baseline+6 weeks, and baseline+12 weeks of each experimental arm
The sample will be characterised in terms of their psychological stress using the Perceived Stress Scale (PSS, Cohen et al., 1983) the Cook-Medley Hostility Scale (Cook & Medley, 1954), and the Spielberger STAI (Spielberger, 1983) administeredat screening. The PSS and the Spielberger MSTAI will also be administered on each test day.
Time frame: Measured at baseline, baseline+6 weeks, and baseline+12 weeks of each experimental arm
Measured using visual analogue scales a regular intervals throughout the test day.
University of Leeds
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05912556
Brain Function, Brain Health
San Francisco, California, United States
View Trial DetailsNCT07047105
Cognition, Fatigue
Newcastle upon Tyne, United Kingdom
View Trial DetailsNCT07387523
Brain Health Activities, Cognition
Barcelona, Catalonia, Spain
View Trial DetailsNCT06995560
Brain Stimulation, Cognition
Charlestown, Massachusetts, United States
View Trial Details